Simon Thompson 

Futura outlines road map ahead

Simon Thompson

Simon Thompson
Futura outlines road map ahead

Futura Medical (FUM:36p), a pharmaceutical company that is developing a portfolio of innovative products based on its proprietary, transdermal Dermasys drug delivery technology focused on sexual health and pain, has been one of the stars of my 2019 Bargain Shares portfolio. The shares have more than doubled in value since I first advised buying them at 14.85p.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now